Literature DB >> 27115756

Burkholderia: an update on taxonomy and biotechnological potential as antibiotic producers.

Eliza Depoorter1,2, Matt J Bull3, Charlotte Peeters1, Tom Coenye2, Peter Vandamme4, Eshwar Mahenthiralingam5.   

Abstract

Burkholderia is an incredibly diverse and versatile Gram-negative genus, within which over 80 species have been formally named and multiple other genotypic groups likely represent new species. Phylogenetic analysis based on the 16S rRNA gene sequence and core genome ribosomal multilocus sequence typing analysis indicates the presence of at least three major clades within the genus. Biotechnologically, Burkholderia are well-known for their bioremediation and biopesticidal properties. Within this review, we explore the ability of Burkholderia to synthesise a wide range of antimicrobial compounds ranging from historically characterised antifungals to recently described antibacterial antibiotics with activity against multiresistant clinical pathogens. The production of multiple Burkholderia antibiotics is controlled by quorum sensing and examples of quorum sensing pathways found across the genus are discussed. The capacity for antibiotic biosynthesis and secondary metabolism encoded within Burkholderia genomes is also evaluated. Overall, Burkholderia demonstrate significant biotechnological potential as a source of novel antibiotics and bioactive secondary metabolites.

Keywords:  Antibiotic biosynthesis; Burkholderia; Genomics; Phylogeny; Secondary metabolism; Taxonomy

Mesh:

Substances:

Year:  2016        PMID: 27115756     DOI: 10.1007/s00253-016-7520-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  74 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  Involvement of Burkholderiaceae and sulfurous volatiles in disease-suppressive soils.

Authors:  Víctor J Carrión; Viviane Cordovez; Olaf Tyc; Desalegn W Etalo; Irene de Bruijn; Victor C L de Jager; Marnix H Medema; Leo Eberl; Jos M Raaijmakers
Journal:  ISME J       Date:  2018-06-13       Impact factor: 10.302

3.  Burkholderia as a Source of Natural Products.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  J Nat Prod       Date:  2019-07-11       Impact factor: 4.050

4.  Genome sequencing and traits analysis of Burkholderia strains reveal a promising biocontrol effect against grey mould disease in grapevine (Vitis vinifera L.).

Authors:  Qassim Esmaeel; Cédric Jacquard; Christophe Clément; Lisa Sanchez; Essaid Ait Barka
Journal:  World J Microbiol Biotechnol       Date:  2019-02-09       Impact factor: 3.312

Review 5.  Twenty years of paradigm-breaking studies of taxonomy and symbiotic nitrogen fixation by beta-rhizobia, and indication of Brazil as a hotspot of Paraburkholderia diversity.

Authors:  Fabiane Paulitsch; Fabio Bueno Dos Reis; Mariangela Hungria
Journal:  Arch Microbiol       Date:  2021-07-10       Impact factor: 2.552

6.  Disruption of Quorum Sensing and Virulence in Burkholderia cenocepacia by a Structural Analogue of the cis-2-Dodecenoic Acid Signal.

Authors:  Chaoyu Cui; Shihao Song; Chunxi Yang; Xiuyun Sun; Yutong Huang; Kang Li; Shuo Zhao; Yongliang Zhang; Yinyue Deng
Journal:  Appl Environ Microbiol       Date:  2019-04-04       Impact factor: 4.792

7.  Burkholderia gladioli MB39 an Antarctic Strain as a Biocontrol Agent.

Authors:  Dinorah A Sarli; Leandro A Sánchez; Osvaldo D Delgado
Journal:  Curr Microbiol       Date:  2021-04-27       Impact factor: 2.188

Review 8.  Regulation of Virulence by Two-Component Systems in Pathogenic Burkholderia.

Authors:  Matthew M Schaefers
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 9.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

10.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.